{"id":453,"date":"2026-08-27T10:31:11","date_gmt":"2026-08-27T10:31:11","guid":{"rendered":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"tesamorelin-hiv-lipodystrophy-randomized-trials","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/tesamorelin-hiv-lipodystrophy-randomized-trials\/","title":{"rendered":"Tesamorelin- und HIV-assoziierte Lipodystrophie: Was randomisierte Studien gemessen haben"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">Tesamorelin ist ein Wachstumshormon-Releasing-Faktor-Analogon mit definierter klinischer Evidenzbasis bei Erwachsenen mit HIV-assoziierter Lipodystrophie. Dieser spezifische Bev\u00f6lkerungs- und Endpunktkontext ist von wesentlicher Bedeutung: Die Beweise sollten nicht zu einer allgemeinen Behauptung der Verbraucher zur Gewichtsabnahme verallgemeinert werden.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Wichtige Erkenntnisse<\/h2><ul class=\"wp-block-list\"><li>In Schl\u00fcsselstudien wurde das viszerale Fettgewebe bei Erwachsenen mit HIV-assoziierter Bauchfettansammlung gemessen.<\/li><li>Auf dem FDA-Etikett steht, dass das zugelassene Produkt nicht f\u00fcr die Gewichtsabnahme geeignet ist.<\/li><li>Der Nachweis eines zugelassenen Produkts stellt keine Gleichwertigkeit f\u00fcr ein unabh\u00e4ngig bereitgestelltes Forschungsmaterial dar.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1672\" height=\"941\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/tesamorelin-hiv-visceral-fat-research.png\" alt=\"Forscher \u00fcberpr\u00fcften anonymisierte Abdomenbildgebung in einer HIV-assoziierten Lipodystrophie-Studie\" class=\"wp-image-444\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/tesamorelin-hiv-visceral-fat-research.png 1672w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/tesamorelin-hiv-visceral-fat-research-300x169.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/tesamorelin-hiv-visceral-fat-research-1024x576.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/tesamorelin-hiv-visceral-fat-research-768x432.png 768w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/tesamorelin-hiv-visceral-fat-research-1536x864.png 1536w\" sizes=\"auto, (max-width: 1672px) 100vw, 1672px\" \/><figcaption class=\"wp-element-caption\">Urspr\u00fcngliche redaktionelle Illustration einer \u00dcberpr\u00fcfung der abdominalen Bildgebung in einer HIV-assoziierten Lipodystrophie-Studie; Es ist kein Patient oder Produkt abgebildet.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Der biologische und klinische Kontext<\/h2><p class=\"wp-block-paragraph\">Tesamorelin ist ein Analogon des Wachstumshormon-Releasing-Faktors. In der untersuchten Umgebung stimuliert es die Freisetzung von Wachstumshormonen aus der Hypophyse und erh\u00f6ht die IGF-1-Signal\u00fcbertragung. In die relevanten Studien wurden Menschen mit HIV aufgenommen, die im Rahmen einer antiretroviralen Therapie \u00fcbersch\u00fcssiges Bauchfett hatten.<\/p><p class=\"wp-block-paragraph\">Dieser Kontext ist wichtig, da HIV-assoziierte Lipodystrophie nicht mit allgemeiner Fettleibigkeit austauschbar ist und das durch Bildgebung gemessene viszerale Fettgewebe nicht derselbe Endpunkt ist wie der Gesamtgewichtsverlust.<\/p><h2 class=\"wp-block-heading\">Was die randomisierte 12-Monatsstudie ergab<\/h2><p class=\"wp-block-paragraph\">Eine randomisierte, placebokontrollierte Studie mit 404-Teilnehmern verwendete viszerales Fettgewebe als prim\u00e4ren Endpunkt. Die Forscher berichteten \u00fcber eine Verringerung des viszeralen Fetts w\u00e4hrend der ersten randomisierten Phase und eine Persistenz bei den Teilnehmern, die die Behandlung fortsetzten. Die Verbesserungen gingen nach der Umstellung von Tesamorelin auf Placebo verloren, was dabei hilft, die Abh\u00e4ngigkeit des beobachteten Effekts von der fortgesetzten Exposition in diesem Protokoll zu kl\u00e4ren.<\/p><p class=\"wp-block-paragraph\">In einer kleineren randomisierten Studie wurden auch Leberfett und viszerales Fettgewebe untersucht. Die Ergebnisse waren explorativ f\u00fcr leberbezogene Ergebnisse und sollten nicht in eine zugelassene Indikation f\u00fcr Lebererkrankungen umgewandelt werden.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Bev\u00f6lkerung<\/strong><span>Erwachsene mit HIV und \u00fcbersch\u00fcssigem Bauchfett<\/span><\/div><div class=\"pim-evidence-row\"><strong>Prim\u00e4re Messung<\/strong><span>Viszerales Fettgewebe durch Bildgebung<\/span><\/div><div class=\"pim-evidence-row\"><strong>Wichtige Einschr\u00e4nkung<\/strong><span>Keine allgemeine Gewichtsmanagementpopulation oder Indikation<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Beschriften Sie Grenzen, die in jede Zusammenfassung geh\u00f6ren<\/h2><p class=\"wp-block-paragraph\">Das 2025 EGRIFTA WR-Etikett identifiziert eine bestimmte zugelassene Formulierung und Indikation. Es wird au\u00dferdem darauf hingewiesen, dass die langfristige kardiovaskul\u00e4re Sicherheit nicht nachgewiesen wurde und dass das Produkt nicht f\u00fcr die Gewichtsabnahme indiziert ist. Diese Einschr\u00e4nkungen sind Teil der Beweise und kein optionales Kleingedrucktes.<\/p>","protected":false},"excerpt":{"rendered":"<p>Eine evidenzbasierte \u00dcberpr\u00fcfung von Tesamorelin-Studien bei Erwachsenen mit HIV-assoziierter Bauchfettansammlung, einschlie\u00dflich Endpunkten, Grenzwerten und FDA-markiertem Kontext.<\/p>","protected":false},"author":1,"featured_media":623,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"367","pim_article_type":"Clinical evidence review","pim_evidence_level":"Randomized controlled human trials and FDA labeling","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-27","pim_editorial_note":"Source-checked against the linked primary or authoritative records on 2026-08-27. This is an evidence summary, not independent peer review, medical advice or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"Randomized tesamorelin trial with 12-month extension\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20101189\/\",\"note\":\"Primary human trial; PMID 20101189.\"},{\"title\":\"Randomized trial of visceral and liver fat outcomes\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25038357\/\",\"note\":\"Exploratory liver-fat evidence; PMID 25038357.\"},{\"title\":\"FDA EGRIFTA WR prescribing information\",\"url\":\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/022505s020lbl.pdf\",\"note\":\"Approved-product indication and limitations.\"}]","footnotes":""},"categories":[18],"tags":[],"class_list":["post-453","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-reviews"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured - NHD<\/title>\n<meta name=\"description\" content=\"An evidence-led review of tesamorelin trials in adults with HIV-associated abdominal fat accumulation, including endpoints, limits and FDA-labeled context.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/tesamorelin-hiv-lipodystrophy-randomized-trials\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured\" \/>\n<meta property=\"og:description\" content=\"An evidence-led review of tesamorelin trials in adults with HIV-associated abdominal fat accumulation, including endpoints, limits and FDA-labeled context.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/tesamorelin-hiv-lipodystrophy-randomized-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-27T10:31:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/\"},\"wordCount\":344,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp\",\"articleSection\":[\"Evidence Reviews\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/\",\"name\":\"Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured - NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp\",\"datePublished\":\"2026-08-27T10:31:11+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"An evidence-led review of tesamorelin trials in adults with HIV-associated abdominal fat accumulation, including endpoints, limits and FDA-labeled context.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/tesamorelin-hiv-lipodystrophy-randomized-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tesamorelin- und HIV-assoziierte Lipodystrophie: Was randomisierte Studien gemessen haben \u2013 NHD","description":"Eine evidenzbasierte \u00dcberpr\u00fcfung von Tesamorelin-Studien bei Erwachsenen mit HIV-assoziierter Bauchfettansammlung, einschlie\u00dflich Endpunkten, Grenzwerten und FDA-markiertem Kontext.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/tesamorelin-hiv-lipodystrophy-randomized-trials\/","og_locale":"de_DE","og_type":"article","og_title":"Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured","og_description":"An evidence-led review of tesamorelin trials in adults with HIV-associated abdominal fat accumulation, including endpoints, limits and FDA-labeled context.","og_url":"https:\/\/nhdbio.com\/de\/tesamorelin-hiv-lipodystrophy-randomized-trials\/","og_site_name":"NHD","article_published_time":"2026-08-27T10:31:11+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/"},"wordCount":344,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp","articleSection":["Evidence Reviews"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/","url":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/","name":"Tesamorelin- und HIV-assoziierte Lipodystrophie: Was randomisierte Studien gemessen haben \u2013 NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp","datePublished":"2026-08-27T10:31:11+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"Eine evidenzbasierte \u00dcberpr\u00fcfung von Tesamorelin-Studien bei Erwachsenen mit HIV-assoziierter Bauchfettansammlung, einschlie\u00dflich Endpunkten, Grenzwerten und FDA-markiertem Kontext.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/tesamorelin-hiv-lipodystrophy-randomized-trials-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/tesamorelin-hiv-lipodystrophy-randomized-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Tesamorelin and HIV-Associated Lipodystrophy: What Randomized Trials Measured"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/453","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=453"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/453\/revisions"}],"predecessor-version":[{"id":518,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/453\/revisions\/518"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/623"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=453"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=453"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=453"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}